comparemela.com

Latest Breaking News On - Elevance health trading - Page 1 : comparemela.com

Power Corp of Canada Reduces Position in Elevance Health, Inc (NYSE:ELV)

Power Corp of Canada trimmed its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 22.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,205 shares of the company’s stock after selling 2,919 shares during the quarter. Power Corp of […]

1832 Asset Management L P Purchases 117,620 Shares of Elevance Health, Inc (NYSE:ELV)

1832 Asset Management L.P. increased its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 25.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 579,755 shares of the company’s stock after purchasing an additional 117,620 shares during the period. […]

Dorsey & Whitney Trust CO LLC Has $1 63 Million Stock Position in Elevance Health, Inc (NYSE:ELV)

Dorsey & Whitney Trust CO LLC lessened its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 11.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,455 shares of the company’s stock after selling 436 shares during the quarter. […]

Elevance Health (NYSE:ELV) Upgraded by StockNews com to Strong-Buy

StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a report released on Wednesday morning. Other equities research analysts have also issued reports about the stock. Jefferies Financial Group upped their price target on shares of Elevance Health from $602.00 to $604.00 and gave the […]

Elevance Health (NYSE:ELV) Coverage Initiated at Robert W Baird

Analysts at Robert W. Baird started coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a report released on Thursday, Marketbeat reports. The firm set an “outperform” rating and a $649.00 price target on the stock. Robert W. Baird’s price target would suggest a potential upside of 20.53% from the stock’s previous […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.